We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Product News   Aug 14, 2017

 
BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Methyltransferases have become a major focus of drug discovery for cancer and other diseases driven by epigenetic factors. BellBrook Labs’ new, ultra-sensitive AptaFluor™ SAH Methyltransferase Assay eliminates cost and sensitivity barriers that are slowing the discovery of methyltransferase inhibitors. Credit: BellBrook Labs

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Porvair Reports Ovarian Cancer Project Shows Promise

Product News

Porvair Sciences reports it has agreed with its collaborative partners to make additional investment in the CEAT project.

READ MORE

MOBILion and International Research Team are Awarded Grant for Research in Parkinson's Disease

Product News

MOBILion Systems is collaborating with an international research team to identify alterations in the metabolism of selective glycosphingolipids in the brain.

READ MORE

InSphero Strengthens Scientific Advisory Board To Advance Drug Discovery and Safety Solutions

Product News

InSphero AG, today announced the strengthening of its Scientific Advisory Board (SAB).

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Genomics Research Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE